Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Zhittya's fMRI Study Shows 21.2% Brain Blood Flow Boost in PD
Details : FGF-1, is a naturally occurring biological protein responsible for the growth of new blood vessels in the human body. It is being evaluated for parkinson’s disease.
Product Name : FGF-1
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 27, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Zhittya Genesis Medicine Starts Parkinson’s Disease Clinical Trial
Details : Zhittya’s, Compassionate Use Clinical Trial will utilize Zhittya’s proprietary FGF-1 biological drug in conjunction with a proprietary intranasal device to introduce its medicine into the brain via the nasal cavity.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 01, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : FGF-1, is a naturally occurring biological protein responsible for the growth of new blood vessels in the human body (angiogenesis) and can promote the growth of new neurons (neurogenesis).
Product Name : FGF-1
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 25, 2022
Reset All
